These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17415791)

  • 1. Rate of clinical progression in Parkinson's disease. A prospective study.
    Schrag A; Dodel R; Spottke A; Bornschein B; Siebert U; Quinn NP
    Mov Disord; 2007 May; 22(7):938-45. PubMed ID: 17415791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical measures of progression in Parkinson's disease.
    Poewe W
    Mov Disord; 2009; 24 Suppl 2():S671-6. PubMed ID: 19877235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How common are complications of Parkinson's disease?
    Schrag A; Ben-Shlomo Y; Quinn N
    J Neurol; 2002 Apr; 249(4):419-23. PubMed ID: 11967646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M; Bowron A; Guttman M; Hauser R; Hughes K; Larsen JP; LeWitt P; Oertel W; Quinn N; Sethi K; Stocchi F
    Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and course of health-related quality of life in Parkinson's disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Herlofson K; Alves G
    Mov Disord; 2008 Jul; 23(10):1420-7. PubMed ID: 18512757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
    Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
    Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson's disease.
    Kamei S; Hara M; Serizawa K; Murakami M; Mizutani T; Ishiburo M; Kawahara R; Takagi Y; Ogawa K; Yoshihashi H; Shinbo S; Suzuki Y; Yamaguchi M; Morita A; Takeshita J; Hirayanagi K
    Mov Disord; 2008 Mar; 23(4):566-73. PubMed ID: 18098279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of depression on motor function and disease severity of Parkinson's disease.
    Papapetropoulos S; Ellul J; Argyriou AA; Chroni E; Lekka NP
    Clin Neurol Neurosurg; 2006 Jul; 108(5):465-9. PubMed ID: 16150537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
    Hely MA; Morris JG; Reid WG; Trafficante R
    Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vehicle drivers with Parkinson disease: behavior schedules of a patient sample from the Community of Madrid].
    Giménez-Roldán S; Dobato JL; Mateo D
    Neurologia; 1998 Jan; 13(1):13-21. PubMed ID: 9522578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B; Angersbach D; Jost WH
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.